Clinical research organisation Parexel has acquired all of the outstanding equity securities of privately-owned ClinIntel, a UK-based provider of clinical …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

